• 1. An investigation into the origin of variations in photovoltaic performance using D–D–π–A and D–A–π–A triphenylimidazole dyes with a copper electrolyte?
  Govind Reddy Mol. Syst. Des. Eng., 2021,6, 779-789
• 2. An atlas of endohedral Sc2S cluster fullerenes?
  Li-Hua Gan,Rui Wu,Jian-Lei Tian,Patrick W. Fowler Phys. Chem. Chem. Phys., 2017,19, 419-425
• 3. Acetyl group orientation modulates the electronic ground-state asymmetry of the special pair in purple bacterial reaction centers
  P. K. Wawrzyniak,M. T. P. Beerepoot,H. J. M. de Groot,F. Buda Phys. Chem. Chem. Phys., 2011,13, 10270-10279
• 4. An atomically efficient, highly stable and redox active Ce0.5Tb0.5Ox (3% mol.)/MgO catalyst for total oxidation of methane?
  Juan J. Sánchez,Miguel López-Haro,Juan C. Hernández-Garrido,Ginesa Blanco,Miguel A. Cauqui,José M. Rodríguez-Izquierdo,José A. Pérez-Omil,José J. Calvino,María P. Yeste J. Mater. Chem. A, 2019,7, 8993-9003
• 5. An arsenic trioxide nanoparticle prodrug (ATONP) potentiates a therapeutic effect on an aggressive hepatocellular carcinoma model via enhancement of intratumoral arsenic accumulation and disturbance of the tumor microenvironment?
  Xin Fu,Qing-rong Liang,Rong-guang Luo,Yan-shu Li,Xiao-ping Xiao,Lu-lu Yu,Wen-zhe Shan,Guang-qin Fan J. Mater. Chem. B, 2019,7, 3088-3099

• Solvents and Organic Chemicals Organic Compounds Organic oxygen compounds Organooxygen compounds Ketones
• Solvents and Organic Chemicals Organic Compounds Organic oxygen compounds Organooxygen compounds Carbonyl compounds Ketones

Introduction to 2-chloro-1-(3-chloro-2-hydroxyphenyl)ethan-1-one (CAS No. 75717-49-6)

2-chloro-1-(3-chloro-2-hydroxyphenyl)ethan-1-one, identified by the Chemical Abstracts Service Number (CAS No.) 75717-49-6, is a significant compound in the realm of organic synthesis and pharmaceutical chemistry. This molecule, featuring a chlorinated aromatic ring system and a ketone functional group, has garnered attention due to its versatile applications in the development of bioactive molecules. The structural motif of this compound, particularly the presence of both chloro and hydroxyl substituents on the phenyl ring, makes it a valuable intermediate in synthetic pathways leading to various pharmacologically relevant scaffolds.

The chemical structure of 2-chloro-1-(3-chloro-2-hydroxyphenyl)ethan-1-one can be described as an ethanone derivative where the carbonyl group is attached to a carbon atom that is also bonded to a phenyl ring substituted with two chlorine atoms and one hydroxyl group. This arrangement imparts unique reactivity, making it a useful building block for further functionalization. The electron-withdrawing nature of the chloro groups and the electron-donating effect of the hydroxyl group create a balance that influences both the physical properties and chemical behavior of the compound.

In recent years, there has been growing interest in exploring the potential of 2-chloro-1-(3-chloro-2-hydroxyphenyl)ethan-1-one in medicinal chemistry. Its structural features suggest that it may serve as a precursor for synthesizing molecules with antimicrobial, anti-inflammatory, or even anticancer properties. The presence of multiple heteroatoms (chlorine and oxygen) provides multiple sites for interaction with biological targets, which is a key consideration in drug design.

One of the most compelling aspects of this compound is its role in constructing heterocyclic frameworks, which are prevalent in many biologically active natural products and synthetic drugs. The chloro-substituted phenyl ring can undergo various transformations, such as nucleophilic aromatic substitution or cross-coupling reactions, enabling the introduction of additional functional groups. These reactions are often catalyzed by transition metals, which can facilitate the formation of complex molecular architectures with high precision.

Recent studies have highlighted the utility of 2-chloro-1-(3-chloro-2-hydroxyphenyl)ethan-1-one in the synthesis of kinase inhibitors. Kinases are enzymes that play crucial roles in cell signaling pathways, and their dysregulation is associated with numerous diseases, particularly cancer. By designing molecules that selectively inhibit specific kinases, researchers aim to develop targeted therapies with improved efficacy and reduced side effects. The structural features of 2-chloro-1-(3-chloro-2-hydroxyphenyl)ethan-1-one make it an attractive candidate for such applications, as it can be modified to interact with the active site or allosteric sites of these enzymes.

The synthesis of 2-chloro-1-(3-chloro-2-hydroxyphenyl)ethan-1-one typically involves multi-step organic reactions starting from readily available aromatic precursors. For instance, one common approach involves chlorination followed by condensation reactions to introduce the ketone functionality. The precise control over reaction conditions is essential to achieve high yields and purity, as impurities can significantly affect downstream applications.

In addition to its pharmaceutical relevance, 2-chloro-1-(3-chloro-2-hydroxyphenyl)ethan-1-one has found applications in materials science. Its ability to undergo polymerization or form coordination complexes with metal ions makes it a potential candidate for developing novel materials with specific properties. For example, metal complexes derived from this compound could exhibit luminescent or magnetic behaviors, which are valuable in sensors or electronic devices.

The environmental impact of synthesizing and using 2-chloro-1-(3-chloro-2-hydroxyphenyl)ethan-1-one is another important consideration. As with many organic compounds containing halogen atoms, care must be taken to minimize waste and ensure proper disposal. Green chemistry principles can be applied to develop more sustainable synthetic routes, such as catalytic methods that reduce energy consumption and hazardous byproducts.

Future research directions may focus on exploring new derivatives of 2-chloro-1-(3-chloro-2-hydroxyphenyl)ethan-1-one that exhibit enhanced biological activity or improved pharmacokinetic profiles. Computational methods, such as molecular modeling and virtual screening, can aid in identifying promising analogs before they are synthesized in the laboratory. These approaches can significantly accelerate the drug discovery process by predicting how different structural modifications will affect molecular interactions.

In conclusion, 75717 - 49 - 6 plays a pivotal role in modern chemical synthesis and pharmaceutical research due to its versatile structural features and reactivity profile. Its potential applications span across multiple fields, from drug development to materials science, making it a compound of considerable interest for researchers worldwide.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)